UNICEF Shares a Mother’s Perspective on Point-of-Care
In 2017, UNAIDS estimated 3,300 children under the age of 15 years died from AIDS-related causes in Cameroon. A key challenge is diagnosing and treating infants early in life. Now,
WHO Considerations for Adoption and Use of Multi-disease Testing Devices in Integrated Laboratory Networks
Several new laboratory technologies are available or are being developed to allow for testing of different conditions using disease-specific tests on the same platform. For example
WHO Technical And Operational Considerations For Implementing HIV Viral Load Testing
This publication provides high-level guidance on implementing and scaling up HIV viral load (VL) testing programmes for health ministries and implementation partners, using a three
WHO What’s New In Treatment Monitoring: Viral Load And CD4 Testing
Treatment initiation ART should be initiated in all children, adolescents, pregnant and breastfeeding women and adults living with HIV, regardless of WHO clinical stage and at any
A Proposed Framework for the Implementation of Early Infant Diagnosis Point-of-Care
To reduce morbidity and mortality among HIV-infected children and close the treatment gap for HIV-infected children, there is an urgent need to evaluate existing programmatic and l
Significant Patient Impact Observed Upon Implementation of Point-of-Care Early Infant Diagnosis Technologies in an Observational Study in Malawi
In this Malawi study, ART initiation rates were significantly improved with the implementation of same-day POC EID testing compared with referred, longer-turnaround laboratory-base
Effect of point-of-care early infant diagnosis on antiretroviral therapy initiation and retention of patients: a cluster-randomised trial
In this cluster-randomized controlled trial, Jani et al. evaluated the effect of point-of-care (POC) early infant HIV testing on rates of antiretroviral therapy (ART) initiation an
Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe
Zibusiso Ndlovu, Epidemiologist and Laboratory Advisor with Médecins Sans Frontières, and colleagues demonstrated the feasibility of the GeneXpert multi-disease testing at the ne
June 2018 LabCoP ECHO Session: Technical Area Essential Approaches: New Innovations with Viral Load
This four-step overview of Laboratory African Regional Collaborative (LARC) was presented by Patricia Riley from the International Laboratory Branch of the US Centers for Disease C
Pioneering New Diagnostics: Addressing Challenges and Implications for Point-of-Care Testing in African Settings
Point-of-Care Testing: Why is it important? Imagine yourself in a city at the centre of one of the world’s deadliest disease outbreaks. You watch as your friends and relatives ar